Urgent.News

What's breaking now, across thousands of outlets.

World

Iran rejects Trump claims of US control over Hormuz as 'lies'

Iran's central military commands spokesperson said US president's claim that the United States has control over the Strait of Hormuz is "nothing more than lies and fabrications".

Iran rejects Trump claims of US control over Hormuz as 'lies'

Iran's military spokesperson dismissed US President Donald Trump's assertion that the United States holds control over the Strait of Hormuz as "lies and fabrications." Speaking on Thursday, Ebrahim Zolfaghari claimed the waterway was fully under Iranian control and that no commercial ship or tanker could pass through without permission and supervision from the Iranian armed forces.

Iran has maintained this control since the start of the Middle East war on February 28, requiring vessels to obtain permission and pay transit fees. Trump's claim that the US has "total control" over the strait, coupled with the prospect of a naval blockade, was dismissed by Iran's Basij forces chief Hossein Taeb, who reiterated that the strait remains under Iranian management and security.

Iranian top diplomat Abbas Araghchi also criticized the US's "miscalculations" regarding the waterway, accusing them of failing intelligence assessments. Iranian lawmakers and security commission member Behnam Saeedi further stated that US and Israeli ships would not be permitted to pass through the Strait of Hormuz under any circumstances, while also noting that an alternative route through the strait, if negotiated, would not automatically open the waterway unless Iran's demands were met.

Written by urgent.news from Channel News Asia's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Read the original at channelnewsasia.com →

More in World

Why vital chemotherapy drugs are in short supply in India

Prices for platinum—the core raw material used in cisplatin and carboplatin—more than doubled, making old price-controlled manufacturing rates financially unviable; additionally, shipping constraints through West Asia have restricted raw material imports from global suppliers.

Why vital chemotherapy drugs are in short supply in India

Prices for platinum—the core raw material used in cisplatin and carboplatin—more than doubled, making old price-controlled manufacturing rates financially unviable; additionally, shipping constraints through West Asia have restricted raw material imports from global suppliers.

More from Thursday 13 August →